Clinical Trial Update: Effects of Semaglutide on Nicotine Intake [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating semaglutide for reducing nicotine intake in adults with tobacco use disorder; the study has completed and results were posted on 2025-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Tobacco Use Disorder, Nicotine Addiction | Phase 2 | Status: COMPLETED | Results posted: 2025-07-18